The reduced metastability ofbiliary cholesterol in the gail bladder bile of patients with cholesterol gail stones has been well shown.
Biliary supersaturation with cholesterol is a prerequisite for cholesterol gall stone formation. Patients without cholesterol gall stones (gall stone free and pigment gall stone patients), however, often have bile supersaturated with cholesterol.' These findings suggest that factors, in addition to biliary cholesterol saturation, are responsible for the formation of cholesterol gall stones. The stability of biliary cholesterol verified by the first appearance of cholesterol monohydrate crystals (nucleation time), rather than the cholesterol saturation index (CSI), is considered to be a better index for differentiating bile metastability.
I Cholesterol nucleation occurs from phospholipid cholesterol vesicles,' the main carriers of cholesterol in addition to bile acid phospholipid cholesterol mixed micelles. Cholesterol nucleation is preceded by vesicle aggregation and fusion,7'8 and is believed to be an initial step in the formation of cholesterol gall stones.
Changes in biliary lipid composition such as high CSI, high bile acid/phospholipid molar ratio or low bile acid concentration accelerates cholesterol nucleation associated with a greater distribution of vesicular cholesterol.47 9 "' Recently, a high total lipid concentration has been reported to reduce the metastability of bile.'"" Furthermore, a high biliary concentration of total protein is reported to reduce bile metastability.'2 14 The importance of pro'1'7 and anti-nucleating protein '8 19 in bile has been shown. Thus, the metastability of biliary cholesterol is modulated by several factors such as biliary lipid composition, total lipid concentration, biliary protein, and the presence of stable/unstable vesicles.
Changes in the gall bladder, such as the increased absorption of water20"2 and the hypersecretion of mucous glycoprotein2"2 have also been shown to be responsible for cholesterol gall stone formation. There has been little investigation, however, as to how the metastability of hepatic bile changes in the gall bladder of patients with or without cholesterol gall stones. Furthermore, despite a possible difference in the cholesterol metastability of hepatic bile between the patients with cholesterol gall stones and control subjects, the nucleation time in hepatic bile has not been compared. We 31 Briefly, 1 ml of 50-100 fold diluted bile was added to lml of trichloroacetic acid solution (final concentration 10%) and placed at 4°C for 30 minutes. The solution was centrifuged at 1700 g for 30 minutes at 4°C. This procedure was repeated twice. After discarding the supernatant, the precipitate was washed with diethyl ether/ethanol (3:1 vol/vol) and then centrifuged as above. The delipidation procedure was also repeated twice. The final pellet was dissolved in borate buffer (pH 9-0) and incubated overnight at 4°C. 0-5 ml of fluorescamine solution (0 03% in acetone) (Sigma, St Louis, MO, USA) was added to 1 5 ml of each sample. After 15 minutes, fluorescence was measured at an excitation wavelength of 390 nm and an emission wavelength of 480 nm by means of fluorescence spectrophotometry (RF-500, Shimadzu, Kyoto, Japan) using bovine serum albumin as the standard.
STATISTICAL ANALYSIS
Data are represented as mean (SD). Differences were tested by the Mann-Whitney U test for unpaired data and the Wilcoxon signed rank test for paired data. The least square method was used in calculating the correlations. A probability value less than 0 05 was considered to be statistically significant.
Results NUCLEATION TIME Figure 1 shows that the nucleation time of hepatic bile in the patients with cholesterol gall stones (8-2 (7-2) days) was significantly shorter (p<O005) than that in the gall stone free patients (15 7 ( 5 8) In gall bladder bile, no significant differences were seen between the two groups in the concentrations of each biliary lipid and total lipid. The composition of individual bile acids was similar between the groups. The molar per cent of cholesterol in gall bladder bile did not differ significantly between the groups (9-2 (1-9) v 8-6 (1-8)%). The CSI in gall bladder bile of the cholesterol gall stone patients, however, was significantly greater (p<005) than that of the gall stone free patients. No significant difference in total protein concentration was seen in gall bladder bile between the cholesterol gall stone patients and the gall stone free patients.
DIFFERENCE IN DISTRIBUTION OF VESICULAR CHOLESTEROL
The relative distribution of vesicular cholesterol in hepatic bile of the cholesterol gall stone patients was higher than that ofthe gall stone free patients, but not to a significant extent (42-3 (14-9)% v 21-9 (21-0)%). In gall bladder bile, a significantly greater distribution of vesicular cholesterol was found in the cholesterol gall stone patients compared with the gall stone free patients (19-7 (11-9)% v 4-4 (1-4)%, p<001) (Table) . RELATION correlated with total lipid conc two groups were combined (F. p<005). Such a significant cc ever, was absent in each bile san the cholesterol gall stone patien gall stone free patients (r=0-02) was found between the nucleatic total protein concentration or thi vesicular cholesterol in hepatic b In gall bladder bile, the nucl inversely correlated significantl (r=-0 51, p<0 05) and with th vesicular cholesterol (r= -0-6 1, combined samples from the tv considered (Fig 3) . When In addition, the nucleation time from more concentrated gall bladder bile has been reported to be quicker than that from hepatic bile in cholesterol gall stone patients. 24 The reported nucleation times of hepatic bile from cholesterol gall stone patients were 9-8 (8 6),' 7 3 (6 5),24 and 8 8 (7 0) days,33 comparable with our finding of 8 2 (7 2) days. There have been no studies reported, however, on the nucleation time 6f
hepatic bile in gall stone free patients. In this study, hepatic bile of the cholesterol gall stone patients provided a significantly shorter nucleation time than that of the gall stone free patients. (total lipid concentration < 10 g/l) possibly has an error as described by Carey,30 the molar per cent of cholesterol was also similar between the two groups. There was no correlation between the entration when nucleation time and the CSI in hepatic bile. The ig 2; r=-0 53, total protein concentration in hepatic bile did not )rrelation, how-differ between the two groups as shown by nple taken from Gallinger et al,'4 and was not connected with the ts (r= -0-43) or nucleation time. The total lipid concentration . No correlation was greater in the hepatic bile of patients with in time and CSI, cholesterol gall stones than that in the gall stone e distribution of free patients (Table) . This may imply that the ifle.
difference in total lipid concentration of diluted Leation time was bile has a greater influence on the nucleation time Ly with the CSI compared with that of concentrated bile, as e distribution of shown in model bile.70 In this study, the hepatic , p<005) when bile was possibly mixed with newly secreted bile, vo groups were as time was required to collect the necessary sed separately in volume. This explains the lower value of total ts and gall stone lipid concentration in hepatic bile than that in ,nificant correla-retained bile of the common bile duct, but the the CSI (r=0-12 value is within the range of values (8-29 g/l) rith the distribu-reported for hepatic bile collected by T tube (r= -0-02 and drainage.'692634 Previous studies2 4 (Fig 1) . The factors differentiating metastability of gall bladder bile in two populations might be ascribed to the CSI and the distribution of vesicular cholesterol. This is partly supported by the evidence that the CSI and the distribution of vesicular cholesterol differed significantly between the two groups ( Table) despite the lack of significant correlation between the nucleation time and these variables in each group (Fig 3) . In contrast with hepatic bile, a significant difference in the total lipid concentration was not seen in gall bladder bile and the total lipid concentration did not correlate with the nucleation time of gall bladder bile. This may be because of the presence of gall stones, as gall bladder bile is more concentrated in the early stage of cholesterol gall stone formation but becomes diluted depending upon the severity of cholecystitis."1 21 37 The total protein concentration did not differ between the two groups as shown by Yamazaki et al.31 A role of the balance between the activity of pro and anti-nucleating protein has been also suggested to be a differentiating factor for the nucleation time.36 38 A higher ratio of the concentration rate of protein to that of bile acids in gall bladder to hepatic bile was seen in the cholesterol gall stone patients than the gall stone free patients (O 75 (1 -2) v 0 \ 5 (O0 11), p<0 05). This indirect evidence suggests a reduced absorption or increased secretion of protein, or both by the gall bladder leading to a change in the biliary protein fraction, as the gall bladder absorbs biliary protein selectively39 and the increased CSI enhances the secretion of pronucleating protein mucin.2 The study4" that gall bladder bile from cholesterol gall stone patients had a higher concentration of mucin despite a similar total protein concentration compared with the controls supports this possibility. Thus, a higher CSI possibly associated with an increase in the pronucleating protein fraction could induce cholesterol rich vesicles, resulting in a further reduced metastability of gall bladder bile in the cholesterol gall stone patients.
In conclusion, cholesterol gall stone patients produce less metastable hepatic bile compared with gall stone free patients proved by the shorter nucleation time. During the storage in the gall bladder, biliary metastability becomes further reduced only in the cholesterol gall stone patients but not in the gall stone free patients. The gall bladder is the last place to produce bile that is likely to nucleate in the patients with cholesterol gall stones. 
